Leaps by Bayer — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Khloris Bioscienceskhlorisbiosciences.comin𝕏Dec 2018
Khloris Biosciences develops iPSC-based cancer vaccines, using induced pluripotent stem cells to trigger a multi-faceted anti-tumor immune response.
BiotechHealthtechLongevitySouth San Francisco, US
Joseph C. Wu(Director)Lynne A. Bui(Co-Founder, President, CEO, and Chairman of the Board)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.